5 Best Pharma Dividend Stocks To Buy in 2024

Page 1 of 5

In this article, we discuss 5 best pharma dividend stocks to buy in 2024. If you want to read our detailed analysis of the pharma sector and its performance, go directly to read 13 Best Pharma Dividend Stocks To Buy in 2024

5. AbbVie Inc. (NYSE:ABBV)

Number of Hedge Fund Holders: 76

An American multinational pharmaceutical company, AbbVie Inc. (NYSE:ABBV) focuses on immunology, oncology, neuroscience, virology, and general medicine. On February 15, the company reported a quarterly dividend of $1.55 per share, which was consistent with its previous dividend. Overall, it has raised its dividends for 51 consecutive years, which makes ABBV one of the best dividend stocks in the pharma sector. The stock’s dividend came in at 3.49%, as of March 4.

As of the close of Q4 2023, 76 hedge funds tracked by Insider Monkey owned stakes in AbbVie Inc. (NYSE:ABBV), up from 73 in the previous quarter. These stakes are worth over $3.5 billion in total. Among these hedge funds, Marshall Wace LLP was the company’s leading stakeholder in Q4.

Follow Abbvie Inc. (NYSE:ABBV)

Page 1 of 5